Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Psychosis Market?
In recent times, there has been robust growth in the size of the psychosis market. It is expected to expand from $9.88 billion in 2024 to $10.49 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this growth during the historic period include an upsurge in mental health conditions, higher demand for mental health treatments, widespread use of typical antipsychotics, a mounting application of cognitive behavioural therapy, along with the prevalence of global and economic conditions causing stress.
What Growth Rate Is Forecasted for the Psychosis Market by 2029?
The market size for psychosis is anticipated to register robust growth in the subsequent years, with a forecasted worth of $13.13 billion in 2029, and a compound annual growth rate (CAGR) of 5.8%. The expected expansion during this forecast period can be credited to an increasing prevalence of stress-related risk factors, escalating burdens of mental health due to changes in lifestyle, surging government initiatives, a rise in the adoption of mindfulness-based interventions and therapy programs, and increased funding towards mental health research and innovative therapies. Key market trends in the forecast period incorporate the emergence of new drug therapies, advancements in diagnostic technologies, the innovation of injectable drugs, application of biomarkers, and the rising demand for tailored medicines.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21266&type=smp
Which Key Companies Are Shaping the Future of the Psychosis Market?
Major companies operating in the psychosis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Biogen Idec, Dr. Reddy’s Laboratories Ltd., Lundbeck A/S, Gedeon Richter, Alkermes, Supernus Pharmaceuticals, Acadia Pharmaceuticals, Neuron Pharmaceuticals, Mapi Pharma, Astellas Pharma Inc., Newron Pharmaceuticals S.p.A., Anavex Life Sciences, BioXcel Therapeutics
Which Factors Are Driving Demand in the Psychosis Industry?
The escalating number of mental health disorders is anticipated to drive the expansion of the psychosis market. Such conditions affect an individual’s emotional state, cognitive function, behavior, and overall mental wellness. The growing number of these disorders can be attributed to increased stress levels, alterations in lifestyle, feelings of social isolation, economic stresses, and genetic susceptibility. Through early detection, medical intervention, and specialized treatments, psychosis treatment assists those grappling with mental health issues, hence promoting the extensive use of antipsychotic medications and therapy alternatives. To illustrate, the National Alliance On Mental Illness, based in the U.S., projected that by 2024, almost 600,000 hospitalizations each year will be due to psychosis spectrum and mood disorders among Americans aged 18-44. Thus, the surge in mental health disorders propels the expansion of the psychosis market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21266&type=smp
How Is the Psychosis Market Segmented by Several Divisions?
The psychosis market covered in this report is segmented –
1) By Product: Tablet, Capsule, Injection
2) By Disease Type: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Disease Types
3) By Distribution Channel: Online, Offline
4) By End-User: Hospitals, Healthcare Clinics, Speciality Clinics, Other End-Users
Subsegments:
1) By Tablet: Antipsychotic Tablets, Mood Stabilizer Tablets
2) By Capsule: Antipsychotic Capsules, Antidepressant Capsules
3) By Injection: Long-acting Injectable Antipsychotics, Short-acting Injectable Antipsychotics
What are the Emerging Market Trends Driving the Growth of the Psychosis Industry?
Prominent enterprises in the psychosis market are concentrating on the creation of sophisticated virtual reality (VR) psychological treatment to enhance the results of therapy via interactive and individualized mental health programs. VR psychological treatment introduces individuals to regulated, computer-generated atmospheres to mitigate distress, improve cognitive abilities, and develop social skills through guided interventions, providing a secure and efficient procedure for symptom control. For instance, in April 2022, gameChangeVR was introduced by OxfordVR, a digital therapeutics firm based in the US, to direct patients through cognitive behavioral therapy (CBT) in captivating, virtual settings. The mechanized VR therapy, carried out over six weekly episodes, exhibited significant advantages, especially for individuals afflicted with intense psychological difficulties, enhancing their paranoia and life quality in general. This technology has the capability to substantially boost the accessibility to effective mental health treatment, tackling the clinician scarcity issue and presenting a scalable option for the treatment of millions of patients suffering from severe mental disorders.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/psychosis-global-market-report
Which Regions Are Driving Growth in the Psychosis Market?
North America was the largest region in the psychosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21266
This Report Delivers Insight On:
1. How big is the psychosis market, and how is it changing globally?
2. Who are the major companies in the psychosis market, and how are they performing?
3. What are the key opportunities and risks in the psychosis market right now?
4. Which products or customer segments are growing the most in the psychosis market?
5. What factors are helping or slowing down the growth of the psychosis market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model